(AUPH) Aurinia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Aurinia Pharmaceuticals | (AUPH) share price targets
Complete technical analysis of Aurinia Pharmaceuticals (AUPH) by charts plus indicators, forecast predictions and share price targets for Aurinia Pharmaceuticals (AUPH)
Aurinia Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-10 View latest technical analysis
10 day averaged volume of Aurinia Pharmaceuticals is 1494331
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Tue Sep 2024 | 6.56 | 6.87 | 6.93 | 6.54 | 0.901 times |
| 09 Mon Sep 2024 | 6.87 | 7.25 | 7.26 | 6.78 | 1.055 times |
| 06 Fri Sep 2024 | 7.26 | 6.93 | 7.45 | 6.85 | 1.792 times |
| 05 Thu Sep 2024 | 6.91 | 6.95 | 7.02 | 6.82 | 0.999 times |
| 04 Wed Sep 2024 | 6.98 | 6.67 | 7.01 | 6.61 | 0.866 times |
| 03 Tue Sep 2024 | 6.68 | 6.79 | 6.92 | 6.64 | 0.684 times |
| 30 Fri Aug 2024 | 6.81 | 6.91 | 6.98 | 6.72 | 0.755 times |
| 30 Fri Aug 2024 | 6.81 | 6.91 | 6.98 | 6.72 | 0.755 times |
| 29 Thu Aug 2024 | 6.90 | 6.63 | 7.03 | 6.63 | 0.925 times |
| 28 Wed Aug 2024 | 6.61 | 6.70 | 6.96 | 6.60 | 1.579 times |
My analysis of stock is bearish for shortterm, and stock might move down till 6.2 or till 5.7. Use a stoploss of 6.61 and if the stock hits stoploss, then it can shoot up till 7.01
Share price targets for Aurinia Pharmaceuticals (AUPH)
| Target Type | Value |
| Downside Target | 4.99 |
| Downside Target | 5.15 |
| Downside Target | 5.77 |
| Downside Target | 5.93 |
| Downside Target | 6.07 |
| Downside Target | 6.23 |
| Downside Target | 6.52 |
| Upside Target | 6.94 |
| Upside Target | 6.98 |
| Upside Target | 7.03 |
| Upside Target | 7.26 |
| Upside Target | 7.45 |
Intraday share price targets for Aurinia Pharmaceuticals (AUPH)
| Target Type | Value |
| Downside Intraday Target | 6.31 |
| Downside Intraday Target | 6.07 |
| Upside Intraday Target | 7.03 |
| Upside Intraday Target | 7.51 |
| Upside Intraday Target | 6.79 |
Weekly technical analysis of Aurinia Pharmaceuticals (AUPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Tue Sep 2024 | 6.56 | 7.25 | 7.26 | 6.54 | 0.45 times |
| 06 Fri Sep 2024 | 7.26 | 6.79 | 7.45 | 6.61 | 5.754 times |
| 30 Fri Aug 2024 | 6.81 | 6.91 | 6.98 | 6.72 | 0.164 times |
| 30 Fri Aug 2024 | 6.81 | 6.80 | 7.03 | 6.52 | 0.812 times |
| 23 Fri Aug 2024 | 6.76 | 6.25 | 6.94 | 6.23 | 1.189 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Aurinia Pharmaceuticals (AUPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Tue Sep 2024 | 6.56 | 6.79 | 7.45 | 6.54 | 0.267 times |
| 30 Fri Aug 2024 | 6.81 | 5.77 | 7.03 | 5.20 | 1.217 times |
| 31 Wed Jul 2024 | 5.88 | 5.69 | 6.07 | 5.26 | 1.249 times |
| 28 Fri Jun 2024 | 5.71 | 5.37 | 5.77 | 5.15 | 0.744 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aurinia Pharmaceuticals (AUPH)
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term but the sell signal is initial and weak.
Aurinia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aurinia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.87 and Aurinia Pharmaceuticals (AUPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term but the sell signal is initial and weak.
Aurinia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aurinia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.87 and Aurinia Pharmaceuticals (AUPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.